DexCom (DXCM) Sales Issues Case
$DXCM stockholders filed a claim against DexCom for misleading them about its financial prospects and hiding problems with the salesforce.
After the financial results on July 25, 2024, $DXCM dropped by over 40%.
DexCom investors can join this case to be notified about potential recovery.
Case Details:
DexCom promised strong revenue and growth in 2024, saying they would surpass past results and smoothly switch to the new G7 platform.
However, DexCom supposedly hid serious problems with its salesforce, which wasn’t ready for the company’s growth plans.
Then, on July 25, 2024, DexCom revealed poor financial results and cut its revenue forecast, citing missed strategic goals.
After this news, $DXCM fell by over 40% on the next day.
DexCom did not reveal that its salesforce was not prepared to handle the company’s growth plans.